MedTrace Logo

Superior Hypogastric Blockade for Postoperative Pain

NCT03428152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2024-03-13

Study results available
· View outcomes & findings →

Summary

The primary indication for superior hypogastric (SHP) block is visceral pelvic pain, most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate. Percutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy, magnetic resonance or computed tomography. Because of the close proximity of SHP to major vessels, and structures like vertebral column (for posterior) and guts (for anterior) are being on the way of the needle, these percutaneous blocks are associated with serious complications. Performing SHP during hysterectomy surgery, gives advantages to rule out these complications by exploring the whole intraabdominal anatomy.

The investigators' theory is to find out if SHP blocks (during pelvic surgery) are useful for decreasing VAS pain scores and opioid consumption for postoperative pain.

Conditions

  • Superior Hypogastric Plexus Block
  • Hysterectomy
  • Pain, Postoperative
  • Gynecologic Disease

Interventions

PROCEDURE

superior hypogastric block

superior hypogastric blockade during surgery

Sponsors & Collaborators

  • Derince Training and Research Hospital

    lead OTHER

Principal Investigators

  • Hande G. Aytuluk, MD · Derince Training and Research Hospital

  • Gulfem Basol, MD · Derince Training and Research Hospital

  • Ahmet Kale, Prof · Derince Training and Research Hospital

  • Canan Balci, Assoc Prof · Derince Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-09
Primary Completion
2018-07-23
Completion
2018-07-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428152 on ClinicalTrials.gov